Reforms needed for compassionate release of prison inmates

The nation's system of freeing some terminally ill prisoners on grounds of compassionate release is so riddled with medical flaws and procedural barriers that many potentially medically eligible inmates are dying behind bars, say UCSF researchers in a new study.

The research, which calls for an overhaul of current practices, is published online this week in .

"Current compassionate release guidelines are failing to identify seriously ill prisoners who no longer pose a threat to society, placing huge financial burdens on state budgets and contributing to the national crisis of prison overcrowding," says lead author Brie Williams, MD, a UCSF assistant professor of medicine in the division of geriatrics.

The authors call for the development of standardized national guidelines by an independent advisory panel of , geriatrics and correctional healthcare experts. The new guidelines would require a fast-track option to evaluate rapidly dying prisoners and an advocate to help the prisoner navigate the application process.

With an aging inmate population, overcrowded prisons and soaring criminal justice medical costs, many have been calling for broader use of compassionate release.

Inmates are eligible if they have a clinically diagnosed life-limiting illness and if it is legally justifiable to release them into society.

Compassionate release has been in effect in the United States since 1984, and all but five states grant some form of early release to eligible dying prisoners. The number of applications annually for compassionate release is unknown because many prisoners die during the laborious review process which can take months -- even years. Only a small number of inmates are granted the special discharge: in 2008, for example, there were 27 such releases from federal prisons compared to 399 deaths.

To be released from federal incarceration, a prisoner must establish "extraordinary and compelling" reasons. In actuality, say the researchers, prisoners must have a terminal prognosis and be expected to die quickly. Their physicians must be able to predict "not only limited life expectancy, but functional decline as well," say the authors.

Yet predicting how long patients will live is difficult when they suffer from conditions like dementia, advanced liver, heart and lung disease. And for those with cancer and other such diseases, life expectancy and functional abilities can be unpredictable, with declines sometimes occurring only in the last weeks of life.

The result is a "Catch 22," say the authors. If compassionate release is requested too late, eligible prisoners will die before their application is complete. If requested too early, terminally ill prisoners could live longer than expected "and perhaps pose a threat to society."

Other inequities are cited, including those faced by illiterate prisoners, cognitively impaired prisoners unable to complete a written petition, or prisoners with little support from family or friends who need an outside agent to act as an advocate.

"In California, the warden must enable the prisoner to designate an outside agent to act as an advocate," the researchers note. "However, once an advocate is appointed, there are no formal guidelines to help the agent navigate the system."

The authors support a clear delineation between the role of physicians or other healthcare providers, who would assess medical eligibility, from prison officials who would be responsible for balancing medical eligibility with public safety.

The authors also suggest that seriously ill prisoners be categorized into three groups: 1. Prisoners with a terminal illness with poor prognosis; 2. Prisoners with Alzheimer's and related dementia; and 3. Prisoners with serious, progressive, nonreversible illness who have profound functional and cognitive impairments. That breakdown would provide a framework to redesign the current eligibility criteria, the researchers say.

Additionally, the authors recommend that compassionate release programs have a recall mechanism for whose medical conditions improve substantially after release.

add to favorites email to friend print save as pdf

Related Stories

High rates of drug-resistant TB among UK prisoners

Mar 16, 2010

UK prisoners are significantly more likely to have drug resistant TB than other people with the disease, suggests research published ahead of print in the Journal of Epidemiology and Community Health.

Care for prisoners will improve public health

Nov 19, 2010

In a comprehensive global survey, researchers in Texas and England have concluded that improving the mental and physical health of inmates will improve public health.

UK inmates comfortable with diversity

Jan 13, 2010

'Ethnicity, Identity and Social Relations in Prison', carried out by Dr. Coretta Philips of the London School of Economics, explored how prisoners' ethnic identities helped them cope with prison life, and whether such identities ...

Recommended for you

Surrogate offers clues into man with 16 babies

5 hours ago

When the young Thai woman saw an online ad seeking surrogate mothers, it seemed like a life-altering deal: $10,000 to help a foreign couple that wanted a child but couldn't conceive.

Nurses go on strike in Ebola-hit Liberia

6 hours ago

Nurses at Liberia's largest hospital went on strike on Monday, demanding better pay and equipment to protect them against a deadly Ebola epidemic which has killed hundreds in the west African nation.

ALS Ice Bucket Challenge arrives in North Korea

Aug 31, 2014

It's pretty hard to find a novel way to do the ALS Ice Bucket Challenge by now, but two-time Grammy-winning rapper Pras Michel, a founding member of the Fugees, has done it—getting his dousing in the center ...

Cold cash just keeps washing in from ALS challenge

Aug 28, 2014

In the couple of hours it took an official from the ALS Association to return a reporter's call for comment, the group's ubiquitous "ice bucket challenge" had brought in a few million more dollars.

Medtronic spends $350M on another European deal

Aug 27, 2014

U.S. medical device maker Medtronic is building stronger ties to Europe, a couple months after announcing a $42.9 billion acquisition that involves moving its main executive offices across the Atlantic, where it can get a ...

User comments